Cargando…
Transferability of Economic Evaluations of Treatments for Advanced Melanoma
BACKGROUND: Differing methodological requirements and decision-making criteria are recognised as barriers to transferability of cost-effectiveness analysis (CEA) across jurisdictions. OBJECTIVE: We assessed the generic and specific transferability of published CEAs of systemic treatments for advance...
Autores principales: | Gorry, Claire, McCullagh, Laura, Barry, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081651/ https://www.ncbi.nlm.nih.gov/pubmed/31761996 http://dx.doi.org/10.1007/s40273-019-00860-y |
Ejemplares similares
-
Advanced Imaging of Brain Metastases: From Augmenting Visualization and Improving Diagnosis to Evaluating Treatment Response
por: Tong, Elizabeth, et al.
Publicado: (2020) -
The Utility of a Rapid Review Evaluation Process to a National HTA Agency
por: Varley, Áine, et al.
Publicado: (2021) -
Health technology management: the experience of a managed access approach to the reimbursement of dupilumab in Ireland
por: Barrett, Rosealeen, et al.
Publicado: (2023) -
THE ABROGATION OF SHEEP ERYTHROCYTE TOLERANCE IN RATS BY MEANS OF THE TRANSFER OF ALLOGENEIC LYMPHOCYTES
por: McCullagh, Peter J.
Publicado: (1970) -
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
por: Usher, Cara, et al.
Publicado: (2019)